RE:RE:GLUGReally? Becuase I expect we will hear news on partnerships with care groups and at risk work places, new location roll outs, publications/additional data sets:
Continuing through the next twelve months, the Company's focus will be to:
- Drive revenue growth by significantly increasing spend against promotion.
- Position Aristotle + AVRT as the #1 program for early cancer detection for employers with at-risk workforces.
- Fully implement current partnerships with key employer groups using Aristotle + AVRT.
- Present data and analysis with respect to at-risk workforces to demonstrate benefit of Aristotle + AVRT
- Broaden relationships with key oncologists and clinics to enhance the reach of CareOncology/Aristotle with a strong focus on HealthCare Systems in multiple key cities.
- Continue to broaden and deepen Aristotle eg CRC. lung and breast cancer staging.
- Partner and launch in key geographic regions world-wide.
I also see they are participating in the HC Wainwright Global Investment Conference In Person (Sept 12-14, 2022).
frewil11 wrote: I guess we are just waiting for next financing news.